Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 2402-2407, May 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Bayoumy, K.
Right arrow Articles by Reddy, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Bayoumy, K.
Right arrow Articles by Reddy, B. S.

Inhibition of 7,12-Dimethylbenz(a)anthracene-induced Tumors and DNA Adduct Formation in the Mammary Glands of Female Sprague-Dawley Rats by the Synthetic Organoselenium Compound, 1,4-Phenylenebis(methylene)selenocyanate1

Karam El-Bayoumy2, Young-Heum Chae, Pramod Upadhyaya, Carol Meschter, Leonard A. Cohen and Bandaru S. Reddy

Division of Chemical Carcinogenesis, American Health Foundation, Valhalla, New York 10595

We synthesized a novel organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate (XSC), possessing low toxicity by comparison with inorganic Na2SeO3, and several other synthetic organoselenium compounds (K. El-Bayoumy, Cancer Res., 45: 3631–3636, 1985). We tested the effect of XSC treatment during the initiation phase on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma formation. A semipurified high-fat diet containing 80 ppm of XSC (40 ppm as selenium) was fed to 6-wk-old virgin female Sprague-Dawley rats for 2 wk, starting 1 wk before and ending 1 wk after carcinogen treatment. At 7 wk of age, rats were given a single dose of DMBA (5 mg) in 0.2 ml of olive oil by gastric intubation; the experiment was terminated 16 wk later. The development of mammary tumors in those rats that received XSC-supplemented diets was significantly inhibited when compared with the control group (fed the same diet without XSC supplements). This was evident from tumor incidence (percentage of tumor-bearing rats, 88 versus 20) and multiplicity of tumors (mean number of tumors/rat, 3.96 versus 0.28). The finding that XSC acts as a chemopreventive agent in the DMBA mammary tumor model prompted us to examine the effect of dietary XSC on DMBA-DNA binding in both the liver and mammary tissue under conditions identical to those described above for the bioassay. Rats (four/group) were killed 6, 24, 48, and 168 h after [3H]DMBA (5 mg/rat; specific activity, 51.2 mCi/mM) administration. Liver and mammary tissue were obtained and DNA was isolated. Dietary XSC was found to inhibit total DMBA-DNA binding in the mammary tissue, but not in the liver. The most profound effect was observed at early time points, i.e., 24 to 48 h after [3H]DMBA administration. The inhibition in total binding was attributed to a reduction in the formation of the three major adducts derived from bay-region diol-epoxides of DMBA; these were identified as anti-diol-epoxide:deoxyguanosine, syn-diol-epoxide:deoxyadenosine, and anti-diol-epoxide:deoxyadenosine adducts on the basis of their chromatographic characteristics on high-pressure liquid chromatography and on a boronate affinity column. The inhibition of the DMBA-DNA binding in the target tissue provides a plausible explanation for the chemopreventive effect of XSC during the initiation stage of carcinogenesis.

1 This work was supported by National Cancer Institute Grant 46589. This is Paper 11 in the series, "Selenium in Chemoprevention of Carcinogenesis."

2 To whom requests for reprints should be addressed.

Received 7/23/91. Accepted 2/17/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K.-M. Chen, T. E. Spratt, B. A. Stanley, D. A. De Cotiis, M. C. Bewley, J. M. Flanagan, D. Desai, A. Das, E. S. Fiala, S. Amin, et al.
Inhibition of Nuclear Factor-{kappa}B DNA Binding by Organoselenocyanates through Covalent Modification of the p50 Subunit
Cancer Res., November 1, 2007; 67(21): 10475 - 10483.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. El-Bayoumy, A. Das, B. Narayanan, N. Narayanan, E. S. Fiala, D. Desai, C. V. Rao, S. Amin, and R. Sinha
Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer
Carcinogenesis, July 1, 2006; 27(7): 1369 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Cai, L.-N. Mu, H. Lu, Q.-Y. Lu, N.-C. Y. You, S.-Z. Yu, A. D. Le, J. Zhao, X.-F. Zhou, J. Marshall, et al.
Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 294 - 300.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. S. Fiala, O. S. Sohn, C.-X. Wang, E. Seibert, J. Tsurutani, P. A. Dennis, K. El-Bayoumy, R. S. Sodum, D. Desai, J. Reinhardt, et al.
Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E
Carcinogenesis, March 1, 2005; 26(3): 605 - 612.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. A. van den Brandt, M. P. A. Zeegers, P. Bode, and R. A. Goldbohm
Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer: A Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. El-Bayoumy, B. A. Narayanan, D. H. Desai, N. K. Narayanan, B. Pittman, S. G. Amin, J. Schwartz, and D. W. Nixon
Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray
Carcinogenesis, September 1, 2003; 24(9): 1505 - 1514.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton
Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents
Carcinogenesis, February 1, 2002; 23(2): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ghose, J. Fleming, K. El-Bayoumy, and P. R. Harrison
Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-activated Protein Kinase and Fas Pathways
Cancer Res., October 1, 2001; 61(20): 7479 - 7487.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. V. Rao, C-Q. Wang, B. Simi, J. G. Rodriguez, I. Cooma, K. El-Bayoumy, and B. S. Reddy
Chemoprevention of Colon Cancer by a Glutathione Conjugate of 1,4-Phenylenebis(methylene)selenocyanate, a Novel Organoselenium Compound with Low Toxicity
Cancer Res., May 1, 2001; 61(9): 3647 - 3652.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. Tanaka, H. Kohno, M. Murakami, S. Kagami, and K. El-Bayoumy
Suppressing Effects of Dietary Supplementation of the Organoselenium 1,4-Phenylenebis(methylene)selenocyanate and the Citrus Antioxidant Auraptene on Lung Metastasis of Melanoma Cells in Mice
Cancer Res., July 1, 2000; 60(14): 3713 - 3716.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
H. Witschi, D. Uyeminami, D. Moran, and I. Espiritu
Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure
Carcinogenesis, May 1, 2000; 21(5): 977 - 982.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. V. Rao, I. Cooma, J. G.R. Rodriguez, B. Simi, K. El-Bayoumy, and B. S. Reddy
Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate
Carcinogenesis, April 1, 2000; 21(4): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. S. Reddy
Novel Approaches to the Prevention of Colon Cancer by Nutritional Manipulation and Chemoprevention
Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 239 - 247.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Izzotti, A. Camoirano, C. Cartiglia, C. J. Grubbs, R. A. Lubet, G. J. Kelloff, and S. D. Flora
Patterns of DNA Adduct Formation in Liver and Mammary Epithelial Cells of Rats Treated with 7,12-Dimethylbenz(a)anthracene, and Selective Effects of Chemopreventive Agents
Cancer Res., September 1, 1999; 59(17): 4285 - 4290.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. S. Sohn, E. S. Fiala, P. Upadhyaya, Y.-H. Chae, and K. El-Bayoumy
Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats
Carcinogenesis, April 1, 1999; 20(4): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. D. Davis, Y. Feng, D. W. Hein, and J. W. Finley
The Chemical Form of Selenium Influences 3,2'-Dimethyl-4-aminobiphenyl-DNA Adduct Formation in Rat Colon
J. Nutr., January 1, 1999; 129(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Ip
Lessons from Basic Research in Selenium and Cancer Prevention
J. Nutr., November 1, 1998; 128(11): 1845 - 1854.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.